Drug name - Stendra

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6656935 METUCHEN PHARMS Aromatic nitrogen-containing 6-membered cyclic compounds
Apr, 2025

(2 years from now)

CN1440393A METUCHEN PHARMS Cyclic Compound
Sep, 2009

(13 years ago)

CN1657523A METUCHEN PHARMS Cyclic Compound
Dec, 2009

(12 years ago)

IN200200391P4 METUCHEN PHARMS Aromatic Nitrogen-Containing 6-Membered Cyclic Compounds
Sep, 2020

(2 years ago)

IN225614B METUCHEN PHARMS Aromatic Nitrogen-Containing 6-Membered Cyclic Compounds
Sep, 2020

(2 years ago)

EP1219609A1 METUCHEN PHARMS Aromatic Nitrogenous Six-Membered Ring Compounds
Sep, 2025

(2 years from now)

EP1219609A4 METUCHEN PHARMS Aromatic Nitrogenous Six-Membered Ring Compounds
Sep, 2025

(2 years from now)

EP1219609B1 METUCHEN PHARMS Aromatic Nitrogenous Six-Membered Ring Compounds
Sep, 2025

(2 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7501409 METUCHEN PHARMS Preparations for oral administration May, 2023

(6 months from now)

Drugs and Companies using AVANAFIL ingredient

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
50MG TABLET;ORAL Prescription
100MG TABLET;ORAL Prescription
200MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.